Comparison of infliximab and ustekinumab for the treatment of moderate-to-severe psoriasis: an indirect comparison meta-analysis
Comparative Effectiveness Research · 2015
DOI: 10.2147/cer.s42437 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Comparative Effectiveness Research, 2015. Verfasst von Tao Fan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fan, T., Marin, M., Bennett, Sen, S., & Smith (2015). Comparison of infliximab and ustekinumab for the treatment of moderate-to-severe psoriasis: an indirect comparison meta-analysis. Comparative Effectiveness Research. https://doi.org/10.2147/cer.s42437
Vancouver
Fan T, Marin M, Bennett, Sen S, Smith. Comparison of infliximab and ustekinumab for the treatment of moderate-to-severe psoriasis: an indirect comparison meta-analysis. Comparative Effectiveness Research. 2015. doi:10.2147/cer.s42437
BibTeX
@article{Fan2015,
author = {Fan, Tao and Marin, Mihaela and Bennett and Sen, Shuvayu and Smith},
title = {Comparison of infliximab and ustekinumab for the treatment of moderate-to-severe psoriasis: an indirect comparison meta-analysis},
journal = {Comparative Effectiveness Research},
year = {2015},
doi = {10.2147/cer.s42437}
}
EUVIMED